Cancer Family
Hematopoietic and Lymphatic System Neoplasm
CI-CAN-00000022Explore in graph →
Non-malignant4,304 active trials98 approved drugs1,010 evidence items
- NCIt
- C35813
Loading cancer entity…
Cancer Family
CI-CAN-00000022Explore in graph →
Clinical trials
18,827 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00006008 | Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia | completed | Phase 2 | — | Eastern Cooperative Oncology GroupNETWORK | 3 | Jun 21, 2013 | clinicaltrials |
| NCT00737516 | Centralized Cord Blood Registry to Facilitate Unrelated Cord Blood Transplantation | completed | Phase 2 | 3,621 | National Marrow Donor ProgramOTHER | 1 | Jun 21, 2013 | clinicaltrials |
| NCT00002471 | Combination Chemotherapy in Treating Patients With Acute B-Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00019227 | Monoclonal Antibody Therapy in Treating Patients With Leukemia | completed | Phase 1 / Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00217503 | Bortezomib and Antiviral Therapy Followed By Effusion Drainage, Bevacizumab, and Combination Chemotherapy in Treating Patients With Primary Effusion Lymphoma | completed | Phase 2 | 15 | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00460629 | Prophylactic Transfer of Leukemia-reactive T Cells After Allogeneic Transplantation | completed | Phase 1 / Phase 2 | 20 | University Hospital Carl Gustav CarusOTHER | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00993486 | Dose-ranging Study of a Single Administration of T-cell Add-back Depleted of Host Alloreactive Cells in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor | completed | Phase 1 / Phase 2 | 19 | Kiadis PharmaINDUSTRY | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00004215 | Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00005040 | Arsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's Lymphoma | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00005631 | Rituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Large Cell Lymphoma | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00006039 | Interferon Alfa-2b in Treating Patients With Advanced Low-Grade Non-Hodgkin's Lymphoma | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00066599 | Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00195000 | Mylotarg and Ara-C in Untreated Patients Above 60 Years With AML and High-Risk MDS | completed | Phase 2 | 43 | Weill Medical College of Cornell UniversityOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00514696 | Study of the Safety of GCS-100 in Subjects With Chronic Lymphocytic Leukemia(PR-CS008) | completed | Phase 2 | 12 | La Jolla Pharmaceutical CompanyINDUSTRY | 1 | Jun 17, 2013 | clinicaltrials |
| NCT00048737 | Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for Lymphoid Malignancies | completed | Phase 1 / Phase 2 | 70 | M.D. Anderson Cancer CenterOTHER | 1 | Jun 13, 2013 | clinicaltrials |
| NCT00003694 | Homoharringtonine Plus Low-Dose Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia in Chronic Phase | completed | Phase 2 | 60 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00045422 | Interferon Alfa and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia | completed | Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00081133 | Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia | completed | Phase 1 / Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00089349 | Alemtuzumab With or Without Methotrexate and Mercaptopurine in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia | completed | Phase 2 | 25 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00005613 | Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease(CBV) | completed | Phase 2 | 147 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00006373 | Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma | completed | Phase 2 | 27 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00047190 | Tipifarnib in Treating Patients With Myelofibrosis and Myeloid Metaplasia | completed | Phase 2 | 35 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00049192 | Oblimersen and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia | completed | Phase 2 | 43 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00062244 | Oblimersen in Treating Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia | completed | Phase 1 / Phase 2 | 58 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00004905 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Acute Leukemia | completed | Phase 2 | — | Loyola UniversityOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00006345 | Dexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell Lymphoma | completed | Phase 2 | — | Ligand PharmaceuticalsINDUSTRY | 1 | May 30, 2013 | clinicaltrials |
| NCT00059995 | MDX-060 Monoclonal Antibody in Treating Patients With Refractory or Relapsed Lymphoma | completed | Phase 1 / Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00061880 | BCX-1777 in Treating Patients With Refractory Cutaneous T-Cell Lymphoma | completed | Phase 1 / Phase 2 | — | BioCryst PharmaceuticalsINDUSTRY | 1 | May 30, 2013 | clinicaltrials |
| NCT00138164 | Denileukin Diftitox in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | completed | Phase 2 | 50 | Jonsson Comprehensive Cancer CenterOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00262743 | Green Tea Extract in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia | completed | Phase 1 / Phase 2 | 73 | Mayo ClinicOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00873457 | Perifosine in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma | completed | Phase 2 | 16 | Daphne FriedmanOTHER | 1 | May 27, 2013 | clinicaltrials |
| NCT00358644 | Study of Decitabine for Treatment of Older Patients With Acute Myeloid Leukemia (AML) | completed | Phase 2 | 55 | Eisai Inc.INDUSTRY | 1 | May 20, 2013 | clinicaltrials |
| NCT00045695 | Bortezomib in Treating Patients With Waldenstrom's Macroglobulinemia | completed | Phase 2 | 27 | NCIC Clinical Trials GroupNETWORK | 2 | May 17, 2013 | clinicaltrials |
| NCT00001586 | Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): DNA Microarray Gene Expression Analysis | completed | Phase 2 | 105 | National Cancer Institute (NCI)NIH | 1 | May 15, 2013 | clinicaltrials |
| NCT00002714 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease | completed | Phase 2 | — | Stanford UniversityOTHER | 1 | May 15, 2013 | clinicaltrials |
| NCT00022048 | Bevacizumab in Treating Patients With Myelodysplastic Syndrome | completed | Phase 1 / Phase 2 | — | Stanford UniversityOTHER | 1 | May 15, 2013 | clinicaltrials |
| NCT00055783 | Monoclonal Antibody Therapy in Treating Patients With Recurrent Hodgkin's Lymphoma | completed | Phase 2 | — | Stanford UniversityOTHER | 1 | May 15, 2013 | clinicaltrials |
| NCT00070421 | Study of @neWorld: A Virtual Community for Children With Cancer | completed | Phase 1 / Phase 2 | — | Leap of Faith TechnologiesINDUSTRY | 1 | May 15, 2013 | clinicaltrials |
| NCT01144260 | Study of Bafetinib as Treatment for Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL) | completed | Phase 2 | 20 | CytRxINDUSTRY | 1 | May 15, 2013 | clinicaltrials |
| NCT00060255 | High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors | completed | Phase 2 | 451 | Roswell Park Cancer InstituteOTHER | 1 | May 9, 2013 | clinicaltrials |
| NCT00093639 | Everolimus and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia Who Are Not in Complete Cytogenetic Remission After Previous Imatinib Mesylate | completed | Phase 1 / Phase 2 | — | Novartis PharmaceuticalsINDUSTRY | 1 | May 1, 2013 | clinicaltrials |
| NCT00715208 | Phase 2 Study of VELCADE (Bortezomib) in Patients With Relapsed Follicular Lymphoma | completed | Phase 2 | 55 | Millennium Pharmaceuticals, Inc.INDUSTRY | 2 | Apr 29, 2013 | clinicaltrials |
| NCT00003425 | Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect | completed | Phase 1 / Phase 2 | 25 | University of KentuckyOTHER | 1 | Apr 26, 2013 | clinicaltrials |
| NCT00915785 | Azacytidine for the Treatment of Myelodysplastic Syndromes/Acute Myeloid Leukemia (MDS/AML) With High Risk (Chromosome 7 and or Complex) Cytogenetic Abnormalities | completed | Phase 2 | 40 | King's College LondonOTHER | 1 | Apr 24, 2013 | clinicaltrials |
| NCT00003957 | Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma | completed | Phase 2 | 3 | Fox Chase Cancer CenterOTHER | 1 | Apr 17, 2013 | clinicaltrials |
| NCT00008697 | Arsenic Trioxide in Treating Patients With Refractory or Recurrent Acute Promyelocytic Leukemia | completed | Phase 1 / Phase 2 | 13 | Washington University School of MedicineOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT00025038 | Combination Chemotherapy Followed By Donor Bone Marrow or Umbilical Cord Blood Transplant in Treating Children With Newly Diagnosed Juvenile Myelomonocytic Leukemia | completed | Phase 2 | 100 | National Cancer Institute (NCI)NIH | 1 | Apr 11, 2013 | clinicaltrials |
| NCT00739388 | Azacitidine in Treating Patients With Newly Diagnosed Previously Untreated or Secondary Acute Myeloid Leukemia Who Are Unsuitable For Intensive Chemotherapy | completed | Phase 2 | 47 | Swiss Cancer InstituteOTHER | 1 | Apr 10, 2013 | clinicaltrials |
| NCT00002552 | Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma | completed | Phase 2 | 40 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 9, 2013 | clinicaltrials |
| NCT00002908 | Bryostatin 1 in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia | completed | Phase 2 | — | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Apr 5, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Jun 21, 2013source: clinicaltrials